Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment. (2020)
Attributed to:
MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches (MASTERPLANS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/rmdopen-2020-001257
PubMed Identifier: 32723832
Publication URI: http://europepmc.org/abstract/MED/32723832
Type: Journal Article/Review
Volume: 6
Parent Publication: RMD open
Issue: 2
ISSN: 2056-5933